More on WVE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $13.20 |
|
|||
| Open | $13.22 | ||||
| 52 Wk High | $38.50 | ||||
| 52 Wk Low | $8.95 | ||||
| Day High | $13.40 | ||||
| Day Low | $12.93 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,472,830 | ||||
- Citi Opens Catalyst Watch on WAVE Life Sciences (WVE)
- Wave Life Sciences to present WVE-006 trial data at medical conference
- Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
- Form 4 Wave Life Sciences Ltd. For: Feb 26 Filed by: Francis Chris
- Form 10-K Wave Life Sciences Ltd. For: Dec 31
- Form 8-K Wave Life Sciences Ltd. For: Feb 26
- WAVE Life Sciences (WVE) Misses Q4 EPS by 3c
- Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Wave Life Sciences to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Entities mentioned with WVE
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Dividend | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
